Found some info here:



http://www.cancernetwork.com/review-article/d...ian-cancer

The most common side effects were grade 4 neutropenia and fluid retention.
The incidence of febrile neutropenia among patients varied from 8% to 44%. These
studies confirmed the activity of docetaxel in platinum-pretreated patients. In
addition, there was a trend demonstrating that longer treatment-free intervals
and platinum-free intervals were associated with higher response rates. It was
also noteworthy that even the most refractory cases demonstrated a significant
response rate to docetaxel.

- See more at: http://www.cancernetwork.com/review-article/d...4cMQJ.dpuf